Advertisement

Topics

Johnson & Johnson tops Street view as 3Q drug sales surge

08:51 EDT 18 Oct 2016 | Topix

Johnson & Johnson posted a 27 percent jump in third-quarter profit, as restrained spending and soaring prescription drug sales more than offset a dip in consumer health sales. The world's biggest maker of health care products handily beat Wall Street's expectations and raised the lower end of its 2016 profit forecast.

Original Article: Johnson & Johnson tops Street view as 3Q drug sales surge

NEXT ARTICLE

More From BioPortfolio on "Johnson & Johnson tops Street view as 3Q drug sales surge"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...